What you should know:
1. The FDA based its approval on the company’s phase 3 UNIFI clinical trial.
2. Stelara induced and maintained clinical remission in a portion of adult patients with moderate to severe ulcerative colitis. Stelara is the first and only approved biologic therapy for UC that targets the interleukin (IL)-12 and IL-23 cytokines.
3. Stelara was first approved in 2009 to treat adults with moderate to severe plaque psoriasis. It has since received four additional approvals.
For details on the phase three study, click here.
More articles on surgery centers:
7 new ophthalmology centers in 2019
6 hospitals, health systems opening or planning ASCs
Work underway on orthopedic medical office, ASC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
